NCT06924242

Brief Summary

This study aims to investigate, based on existing knowledge, the incidence of occult thyroid carcinoma in a cohort of patients with MNG, providing new insights into the prevalence and characteristics of thyroid malignancies in MNG. It seeks to contribute to optimizing diagnostic evaluations for patients with multinodular goiter.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 11, 2025

Completed
Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

6.4 years

First QC Date

March 28, 2025

Last Update Submit

April 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • incidence of occult thyroid carcinoma

    Incidence of occult thyroid carcinoma in a cohort of patients with multinodular goiter, providing new insights into the prevalence and characteristics of thyroid malignancies.

    6 years

Study Arms (1)

Patient with multinodular goiter who underwent total or partial thyroidectomy

Procedure: total or partial thyroidectomy

Interventions

Total thyroidectomy is a surgical procedure that involves the complete removal of the thyroid gland. It is performed to treat conditions such as thyroid cancer, large goiters, or severe hyperthyroidism. The surgery is typically conducted under general anesthesia through an incision in the lower neck. Postoperative management may include hormone replacement therapy with levothyroxine to compensate for the loss of thyroid function. Potential complications include hypocalcemia due to parathyroid gland injury and vocal cord dysfunction from recurrent laryngeal nerve damage.

Patient with multinodular goiter who underwent total or partial thyroidectomy

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients of both sex with cancer incidence in multinodular thyroid goiter who underwent surgery in the same center

You may qualify if:

  • patients diagnosed with multinodular goiter via thyroid ultrasound, with or without FNA cytology.
  • patients who underwent surgery.
  • availability of complete clinical data

You may not qualify if:

  • history of thyroid carcinoma or other thyroid neoplasms.
  • not completed postoperative follow up.
  • patients with preoperative FNA results indicating malignancy (TIR 4-5), suspicion of malignancy (TIR 3), or indeterminate significance (TIR 1)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Foggia

Foggia, FG, 71122, Italy

Location

MeSH Terms

Conditions

Goiter, NodularThyroid Neoplasms

Condition Hierarchy (Ancestors)

GoiterThyroid DiseasesEndocrine System DiseasesEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck Neoplasms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 11, 2025

Study Start

January 1, 2018

Primary Completion

May 30, 2024

Study Completion

July 31, 2024

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations